Our latest news

GammaDelta Therapeutics will be keeping the global community updated with news about their pioneering research and development for the exploitation of γδ T cells.

GammaDelta Therapeutics receives FDA Clearance of IND Application for GDX012, a novel allogeneic variable delta 1 gamma-delta T cell cancer therapy
20th May 2021
Read more
Innovative biotech firms take new office space at white city place to support accelerating growth plans
19th April 2021
Read more
Adaptate Biotherapeutics formed to develop antibody-based therapies that modulate gamma delta T-cells
16th October 2019
Read more
Paolo Paoletti, CEO of GammaDelta Therapeutics celebrated in the 2019 Maserati 100 Innovators of the year award.
25th March 2019
Read more
GammaDelta Therapeutics to move to London’s White City life sciences cluster
20th December 2018
Read more
GammaDelta Therapeutics announced as winner of the 2018 Outstanding Achievement Award at the OBN Annual Awards Ceremony.
12th October 2018
Read more
GammaDelta Therapeutics Appoints Michael Koslowski as CMO
21st June 2018
Read more
GammaDelta Therapeutics acquires Lymphact to advance their gamma delta (γδ) T-Cell platform into the clinic
12th June 2018
Read more
GammaDelta featured in The Endpoints 11
18th January 2018
Read more
GammaDelta Therapeutics named as one of the top European biotech companies to watch in 2018
11th January 2018
Read more
GammaDelta Therapeutics Q&A Session with Raj Mehta
17th November 2017
Read more
GammaDelta Therapeutics highlighted in press release by the Treasury announcing new investment into the UK life science sector
26th October 2017
Read more
GammaDelta Therapeutics highlighted in CNBC Europe News
7th October 2017
Read more
Betting big on Gamma Delta T Cells
7th August 2017
Read more
This Italian Academic-turned-CEO also Launched 7 Cancer Drugs at GSK
12th June 2017
Read more
GammaDelta’s Scientific Co-Founder Adrian Hayday Receives Inaugural Business of Science Leadership Award
19th May 2017
Read more
Takeda and GammaDelta Therapeutics Announce Collaboration to Advance Tissue-derived gamma delta (γδ) T Cells
9th May 2017
Read more
GammaDelta Therapeutics expands management team led by Paolo Paoletti as CEO
3rd May 2017
Read more